ArticleCell reports. Medicine2026

Metabolically engineered probiotic OMVs as nanovaccine mediating sequential immunomodulation for chronic bone infection immunotherapy.

Jie Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.